[The specific activity and immunological safety of a live mumps vaccine from the Leningrad-3 strain in intranasally revaccinated adult subjects].
Iuminova
N V
NV
Krasnova
V P
VP
Liashenko
V A
VA
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood*; D000917:Antibody Formation; D000918:Antibody Specificity; D004341:Drug Evaluation; D006801:Humans; D007111:Immunity, Cellular; D007117:Immunization, Secondary; D009108:Mumps Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology*; D009109:Mumps virus / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology
D000914:Antibodies, Viral; D009108:Mumps Vaccine; D014613:Vaccines, Attenuated
Spetsificheskaia aktivnost' i immunologicheskaia bezopasnost' zhivoĭ parotitnoĭ vaktsiny iz shtamma Leningrad-3 u intranazal'no revaktsinirovannykh vzroslykh liudeĭ.